Henderson Morley files notice of administration
This article was originally published in Scrip
Executive Summary
The small UK biotechnology firm Henderson Morley has filed a notice of intention to call in the administrators following its failure to secure the divestment of its ICVT (Ionic Contra Viral Therapy) portfolio to KMS Therapeutics, resulting in a suspension of its shares on London's AIM.